- SEK42.40m
- SEK28.72m
- SEK54.22m
Brief: Scandidos Q3 EBITDA Turns To Loss Of SEK 0.1 Mln
Brief: Scandidos Q2 EBITDA Loss Stable at SEK 0.6 Mln
Brief: ScandiDos Gets Order Of EUR 0.4 MLN From Japan
Brief: Scandidos Q1 EBITDA Loss Widens To SEK 5.5 Mln
Brief: Scandidos Q4 EBITDA Swings To Loss Of SEK 0.6 Million
Brief: ScandiDos Receives Order In Japan
Brief: Scandidos Q2 Net Sales Lower To SEK 13.3 Million
Brief: Scandidos Q1 Net Reveune Lowers To SEK 11.7 Mln
Brief: ScandiDos Major Shareholder Buys Additional 10% Of Co
Brief: ScandiDos Selected As Preferred QA Partner By First Radixact Synchrony Customer In France
Brief: ScandiDos Q4 EBITDA Turns To Profit Of SEK 0.5 Mln
Brief: ScandiDos Q3 EBITDA Turns To Profit Of SEK 0.5 Mln
Brief: ScandiDos Q2 EBITDA Loss Turns To Profit SEK 2.4 Mln
Brief: ScandiDos Q1 EBITDA Loss Turns To Profit SEK 0.8 Mln
Brief: ScandiDos Appoints Gustaf Piehl New CEO
Brief: Scandidos AB - Thomas Jefferson University Hospital In Philadelphia Chooses Scandidos As Supplier
Brief: ScandiDos Gets Orders From Hospitals In Algeria
Brief: ScandiDos AB Q2 Net Sales Rise To SEK 12.5 Million
Brief: ScandiDos: Olof Sandén Appointed New Chairman